You are here: Industry Insights > CDMO

News List

GTP Bioways to galvanise CDMO position in France with two new biopharma facilities CPhIonline
October 29, 2021
The specialist biotherapies and nanotherapies producer has said the first line, which will have a capacity of 300 L, will focus on production using microbial systems (bacteria and yeast), and will be operational in early 2023.
Catalent embarks on $230M viral vector expansion project at Harmans campus CPhIonline
October 28, 2021
CDMO Catalent is to spend $230 million on adding three further commercial-scale viral vector manufacturing suites and associated support facilities and services at its gene therapy campus in Harmans, Maryland.
Forge Biologics to provide CDMO support for Solid Biosciences' preclinical gene therapy CPhIonline
October 10, 2021
By providing AAV process development, scale up and cGMP manufacturing services, Forge hopes to bolster Solid's gene therapy pipeline
CPhI Monthly Podcast: Selecting the Right CDMO Outsourcing Partner cphi-online
September 13, 2021
Sponsors within the biopharmaceutical industry are increasingly turning to outsourcing for several reasons; remaining competitive and flexible within a quickly evolving sector...
Room for specialists and one-stop-shops in CDMO space prnewswire
September 13, 2021
In general, contractors try to meet these demands either by offering a broad range of services, covering everything from process development through to fill-finish – so-called “one-stop-shops” - or they specialize in an effort to carve out a niche.
Emerging regional markets show promise as CDMO globalisation trend grows cphi-online
September 08, 2021
This is the consensus view of experts in the biopharmaceutical outsourcing sector who say the pace of growth is showing no signs of slowing down.
Recipharm expands its analytical services offering in India cphi-online
August 26, 2021
The CDMO inaugurates its new analytical laboratory under Recipharm Analytical Solutions
Curia lays out plans to expand complex API manufacturing capacity cphi-online
August 23, 2021
The $35 million investment will more than double the site’s batch-size scaling and product output.
Cell and gene therapy manufacturing services market to value $13.8 billion by 2026 europeanpharmaceuticalreview
August 12, 2021
The global cell and gene therapy manufacturing services market is expected to grow at a CAGR of 12.4 percent in the next five years.
Recro eyes expansion to full-service CDMO status cphi-online
August 12, 2021
The solid oral dose specialist signs letter of intent for acquisition of a CDMO providing a full range of services

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page